Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
To make myself feel more comfortable tonight I could sit and read all of the past RNSs; sit and watch the last few company presentations; or I can sit and listen to Sir Al in his interviews (again and again over and over , sorry I got distracted for a second !) BUT far quicker is to simply ask myself 1 single question:
‘If the US are issuing an emergency FDA approval for a test that still ultimately requires a professional to assist, why the hell would the US not issue an emergency approval to AVCT when we have the only darn spit stick that your average consumer can do themselves ?!!’
Answer: of course they are going to ! ... just wouldn’t be surprised if the UK Gov get to announce it to the world first.
Rest east peeps, GAME CHANGER coming !
Also - do you actually really think Sir Al is overly bothered about whether the RNS lands on a Friday or a Tuesday. I mean really ? ... short term share price is not and will never be his priority nor should we ultimately wish it to be. He is building a global brand and good things will come to those who wait, patiently !
Sir Al congratulated and thanked his staff in an RNS to the world several weeks ago now. Their work has long been done. He has even given them all shares by way of saying thank you, also several weeks ago. We are well on our way to a global ‘sign off’ , the least we can do is keep the faith !
I have been buying, reading, buying, reading then buying some more. Lots to come over the next 6 months. Cheap as chips as they say !!
Superb RNS.
Anyone else noticed the bit at the end of the RNS not in the main text ?
‘Avacta expects to take its first drug, a pre|CISION targeted form of the standard-of-care Doxorubicin, into the clinic later in 2020 or early 2021.’ Eeeek !
And
‘Avacta has established drug development partnerships with pharma and biotech, including with Moderna Therapeutics Inc., a deal with LG Chem worth up to $310m, a partnership with ADC Therapeutics to develop Affimer drug conjugates and has established a joint venture in South Korea with Daewoong Pharmaceutical focused on cell and gene therapies incorporating Affimer immune-modulators. Avacta actively seeks to license its proprietary platforms in a range of therapeutic areas.’
Suggests to me the up front payment has probably been $10million dollars. Sounds healthy to me !
And
‘Avacta diagnostics business unit works with partners world-wide to develop Affimers for evaluation by those third parties with the objective of establishing royalty bearing license deals. The Company is also developing a small in-house pipeline of Affimer-based diagnostic assays for licensing.‘ So, much more to come !!
Enjoy !
Holding six figures and not selling a single one to I have seen this boy follow his role through - Cancer & Nasdaq (potentially) ... a “Galactico” love it. I have absolutely no doubts things are going BIG & very quickly !
100% agree PL75. The fact Sir Al has congratulated his staff IMO means in terms of development the product is ready. It is now onto approvals. Each piece of the jigsaw is falling into line and I have no doubts we will see millions of these tests. I really could not care less what the price movement is today. Any real investor is looking beyond the next few trading days. If you look beyond to even 6 weeks from now, I believe we will be approved by all the necessary bodies and will be ready to sell the test. That's how close we are. It is not this time next year Rodney, this is this time in 6 weeks !
I am not saying we will go NASDAQ this year but I would not be surprised if we did in the second half of next year. The LFT news will send this through the roof. I actually think we are ahead of the game currently. Ignore the noise. When the media and in particular the news channels really gets hold of AVCT our LFT this is going to go ‘chicken oriental’ !!!
The key point here is this is all about ANTIGEN testing. Only Quidel and shortly AVCT will be able to supply these. Yes others will follow but really who cares. We are talking about the whole of the US for next few years and potentially GLOBAL demand. Not being funny but Boris can have ODX etc. It matters not !!
The six states that have con-joined to purchase / order Antigen tests from Quidel are:
Maryland, Louisiana, Massachusetts, Michigan, Ohio and Virginia.
Governors for these six states stated today: “Rapid access to testing is crucial in our collective fight against Covid-19, which is why I am grateful to join these other governors in a collaborative effort to purchase testing supplies and help identify outbreaks more quickly, while improving the turnaround time for test results."
“Covid does not know any borders and by working together we strengthen our response, improve testing access and ultimately help our communities become safer and healthier.”
“Time is of the essence, which is why I am pleased to join with my fellow governors to work together to expand the use of rapid, point-of-care antigen tests in order to help to slow the spread of Covid-19 in our states."
“The states are leading America’s national response to Covid-19,” said Governor Northam. “We are bringing together this bipartisan, multi-state coalition to combine our purchasing power and get rapid testing supplies to our communities as quickly as possible. The people in our six states want to see action, and we’re delivering.”
D Trump cannot ignore this statement of intent for six US states (others are bound to follow). He cannot ignore the recommendations of the Rockefeller Report for very long. AVCT will almost certainly get the lions share of future orders providing we are easier to use, provide faster results and less false negatives. Sir Alan has already said we are within the "clinical range" so I am very confident we will be all of the above. Not long now.
I have said it before and will say again the US market is where we will make our name. Only 1 single Antigen test has been approved, yes 1 test, and the US states are joining together and ordering these tests by the bucket load. The Rockefeller report which is now the 'go to' document of what the US government 'should be doing' says Antigen testing and preferably saliva-based tests is the best possible way of dealing with the virus. The Quidel tests throws far too many false negatives (1 in 10 I think) which is not really good enough for mass screening. Our test will produce results faster, with less false negatives and is saliva based. The Quidel test requires a nasal swap. That is our nearest competitor. Genedrive has gone nuts today because they have been linked with a big US pharma and everyone say that means FDA approval is nailed on. We already have our big US pharma in Cytivia. The Rockefeller reports actually tells the US Government to lower standards so that FDA approvals can be fast-tracked. I really feel that there are too many 'sign-posts' telling us that AVCT will be the game-changing test and new gold standard, potentially GLOBALLY for some time. Be patient. Keep adding. You will be rewarded IMO !
Myles - you are an inspiration and a very intelligent guy. Keep it up. I and many people I know have lots of deeply held respect for you & the insight you provide. Best Regards to you.
Also to Rich Ken and all other informative posters.
All - try to ignore the noise. Top up when you can, like this morning. Read and re-read every RNS carefully. All is good and we all, I am certain, will be handsomely rewarded !
Was forced to sell some DDDD and SAE to take advantage of the drop this morning. Shocked it dropped through £140 to £130 but can easily see this back into mid-£140s by close of play. Laughable that as AVCT dropping BBC news reporting monitoring of sewage / foul water a way forward for COVID testing. Buy on the dips. Long and strong. Patience pays off !
Tony what a ridiculous comment to make ! In the share since April but not aware AVCT are part of the U.K. Gov backed scheme that is trailing tests right now which includes our LFT. Do you actually have any idea what you are invested in ? Take this extra time to read RNS, they are all on Avactas website. I am sure having read them all properly you will be very happy with your investment. If you have any time, also read the Rockafella Report recently published in the US - it outlines that an antigen test that is quick, easy to use and saliva based is the recommended way forward and it tells Trump to focus US resources in any tests that propose to do that and that all approvals should be fast tracked. Stop trying to set a negative tone on a Monday morning. There really is no call for it.
Well I did say !!!
Us is our market - HUGE!
From this morning I stated:
The findings of the Rockafella-report are HUGE. Basically saying rapid antigen testing is where the focus should be for the whole of America. This is because it is the cheapest & quickest way to establish if someone is infected or not. They have even lowered the ‘bar’ for approval so that they can get them onto the market even quicker. It recommends towards the end that approvals should be fastracked and that efforts should be concentrated so this happened as soon as possible. Can you image D Trump reading this ? He’ll have skipped to the last page anyway and will he looking for the nearest pen on where to sign!! He knows he can’t ignore the advice in this report. It is superb news for Avacta holders IMO. I have always been of the view that America was where we were heading and for me, this report confirms it. Don’t get me wrong, very nice to be part of the UK initiative and of course helpful for the BAMs etc which will generate income on its own, but really the LFT as we all know is where the real dollars will be made. Oh and don’t forget the neutralising therapy , that’s the carrot for a licensing deal with Big Pharma. No need for a buy out , we are heading there anyway !!
Rest up. Big weeks ahead !
The findings of the Rockafella-report are HUGE. Basically saying rapid antigen testing is where the focus should be for the whole of America. This is because it is the cheapest & quickest way to establish if someone is infected or not. They have even lowered the ‘bar’ for approval so that they can get them onto the market even quicker. It recommends towards the end that approvals should be fastracked and that efforts should be concentrated so this happened as soon as possible. Can you image D Trump reading this ? He’ll have skipped to the last page anyway and will he looking for the nearest pen on where to sign!! He knows he can’t ignore the advice in this report. It is superb news for Avacta holders IMO. I have always been of the view that America was where we were heading and for me, this report confirms it. Don’t get me wrong, very nice to be part of the UK initiative and of course helpful for the BAMs etc which will generate income on its own, but really the LFT as we all know is where the real dollars will be made. Oh and don’t forget the neutralising therapy , that’s the carrot for a licensing deal with Big Pharma. No need for a buy out , we are heading there anyway !!
Big weeks ahead !
The findings of the R-report are HUGE. Basically saying rapid antigen testing is where the focus should be for the whole of America. This is because it is the cheapest & quickest way to establish if someone is infected or not. They have even lowered the ‘bar’ for approval so that they can get them onto the market even quicker. It recommends towards the end that approvals should be fastracked and that efforts should be concentrated so this happened as soon as possible. Can you image D Trump reading this ? He’ll have skipped to the last page anyway and will he looking for the nearest pen on where to sign!! He knows he can’t ignore the advice in this report. It is superb news for Avacta holders IMO. I have always been of the view that America was where we were heading and for me, this report confirms it. Don’t get me wrong, very nice to be part of the UK initiative and of course helpful for the BAMs etc which will generate income on its own, but really the LFT as we all know is where the real dollars will be made. Oh and don’t forget the neutralising therapy , that’s the carrot for a licensing deal with Big Pharma. No need for a buy out , we are heading there anyway !!
Rest up. Big weeks ahead !